Blocking of acid-fixed nuclear binding of Epstein-Barr virus nuclear antigen (EBNA) by different DNA species.
Treatment of Epstein-Barr virus-determined nuclear antigen (EBNA) with DNA resulted in blocking of its ability to convert acid-fixed EBNA-negative cell nuclei to an EBNA-positive form. Epstein-Barr virus (EBV) DNA, herpes simplex virus type 2 (HSV-2) DNA and DNA isolated from three lymphoblastoid cell lines differed in their potency to block this reaction. EBV DNA was found to be about three times more effective than cellular DNAs in abolishing the ability of DNA-cellulose-purified EBNA to convert acid-fixed nuclei to the EBNA-positive form; the effect of HSV-2 DNA was of intermediate character. No difference was found between the blocking potency of DNAs isolated from EBV-genome-negative Ramos cells and EBV-genome-positive Raji and P3HR-1 cells.
D000956:Antigens, Viral / Q000032:analysis; D002460:Cell Line; D002467:Cell Nucleus / Q000276:immunology / Q000378:metabolism; D004265:DNA Helicases / Q000378:metabolism*; D004273:DNA, Neoplasm / Q000378:metabolism*; D004279:DNA, Viral / Q000378:metabolism*; D004854:Herpesvirus 4, Human / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D018139:Simplexvirus / Q000378:metabolism; D013045:Species Specificity; D014764:Viral Proteins / Q000378:metabolism*
D000956:Antigens, Viral; D004273:DNA, Neoplasm; D004279:DNA, Viral; D014764:Viral Proteins; D004265:DNA Helicases